Investing.com - Lifestance Health Group (NASDAQ: LFST) reported second quarter EPS of $-0.13, $0.05 worse than the analyst estimate of $-0.08. Revenue for the quarter came in at $259.6M versus the consensus estimate of $255.19M.
Lifestance Health Group's stock price closed at $8.68. It is up 1.64% in the last 3 months and up 10.43% in the last 12 months.
Lifestance Health Group saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Lifestance Health Group's stock price’s past reactions to earnings here.
According to InvestingPro, Lifestance Health Group's Financial Health score is "good performance".
Check out Lifestance Health Group's recent earnings performance, and Lifestance Health Group's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar